Improvement of exertional dyspneoa in patients with chronic obstructive pulmonary disease and severe allergic asthma responding to omalizumab.
Clin Exp Allergy
; 53(12): 1298-1301, 2023 12.
Article
in En
| MEDLINE
| ID: mdl-37705326
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Asthma
/
Anti-Asthmatic Agents
/
Pulmonary Disease, Chronic Obstructive
/
Hypersensitivity
Limits:
Humans
Language:
En
Journal:
Clin Exp Allergy
Journal subject:
ALERGIA E IMUNOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: